ES2103280T3 - Anticuerpos monoclonales que inhiben el crecimiento del sarcoma de kaposi. - Google Patents

Anticuerpos monoclonales que inhiben el crecimiento del sarcoma de kaposi.

Info

Publication number
ES2103280T3
ES2103280T3 ES91104816T ES91104816T ES2103280T3 ES 2103280 T3 ES2103280 T3 ES 2103280T3 ES 91104816 T ES91104816 T ES 91104816T ES 91104816 T ES91104816 T ES 91104816T ES 2103280 T3 ES2103280 T3 ES 2103280T3
Authority
ES
Spain
Prior art keywords
growth
monoclonal antibodies
oncostatin
kaposi sarcoma
kaposi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91104816T
Other languages
English (en)
Inventor
Syed Zaki Salahuddin
Shuji Nakamura
Robert C Gallo
Susan F Radka
Peter S Linsley
Mohammed Shoyab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
US Department of Health and Human Services
Original Assignee
Oncogen LP
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP, US Department of Health and Human Services filed Critical Oncogen LP
Application granted granted Critical
Publication of ES2103280T3 publication Critical patent/ES2103280T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE ANTICUERPOS MONOCLONALES ESPECIFICOS PARA LA ONCOSTATINA M PARA INHIBIR EL EFECTO QUE POTENCIA EL CRECIMIENTO DE LA ONCOSTATINA M SOBRE EL SASCOMA DE KAPOSI ASOCIADO CON EL SIDA. DE MODO PARTICULAR, LA NEUTRALIZACION DE ANTICUERPOS ANTI-ONCOSTATINA M INHIBE EL CRECIMIENTO DEL SARCOMA DE KAPOSI QUE ES POTENCIADO Y MANTENIDO POR LA ONCOSTATINA M O UN FACTOR ENCONTRADO EN MEDIOS ACONDICIONADOS DE UNA LINEA DE LA CELULA T TRANSFORMADA DE HTLV-II .
ES91104816T 1990-03-29 1991-03-26 Anticuerpos monoclonales que inhiben el crecimiento del sarcoma de kaposi. Expired - Lifetime ES2103280T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50214190A 1990-03-29 1990-03-29

Publications (1)

Publication Number Publication Date
ES2103280T3 true ES2103280T3 (es) 1997-09-16

Family

ID=23996528

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91104816T Expired - Lifetime ES2103280T3 (es) 1990-03-29 1991-03-26 Anticuerpos monoclonales que inhiben el crecimiento del sarcoma de kaposi.

Country Status (12)

Country Link
EP (1) EP0450472B1 (es)
JP (1) JP3076926B2 (es)
KR (1) KR910016344A (es)
AT (1) ATE153075T1 (es)
CA (1) CA2039230C (es)
DE (1) DE69126060T2 (es)
DK (1) DK0450472T3 (es)
ES (1) ES2103280T3 (es)
GR (1) GR3024336T3 (es)
HU (1) HUT57274A (es)
IL (1) IL97622A (es)
ZA (1) ZA912137B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783672A (en) 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
WO2001035903A2 (en) * 1999-11-16 2001-05-25 Kurnick, James, T. Compositions and methods for regulating tumor-associated antigen expression
US20170327573A1 (en) * 2014-09-24 2017-11-16 Universitá Degli Studi Di Padova Composition to induce bone marrow stem cell mobilization
TWI904261B (zh) 2020-10-19 2025-11-11 美商碩騰服務公司 犬及貓抑瘤素Ｍ受體β之抗體及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
CA2039230A1 (en) 1991-09-30
ZA912137B (en) 1992-11-25
HK1005038A1 (en) 1998-12-18
DK0450472T3 (da) 1997-11-03
IL97622A (en) 1997-06-10
ATE153075T1 (de) 1997-05-15
JP3076926B2 (ja) 2000-08-14
GR3024336T3 (en) 1997-10-31
IL97622A0 (en) 1992-06-21
HU911005D0 (en) 1991-10-28
DE69126060D1 (de) 1997-06-19
CA2039230C (en) 2002-07-30
EP0450472B1 (en) 1997-05-14
KR910016344A (ko) 1991-11-05
DE69126060T2 (de) 1997-12-11
JPH06340551A (ja) 1994-12-13
EP0450472A1 (en) 1991-10-09
HUT57274A (en) 1991-11-28

Similar Documents

Publication Publication Date Title
FI935555A0 (fi) Nya sulfonamider
NL300224I2 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl- of indanylalkylaminoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
TR199700844T1 (xx) Pirazolil-Benzoil T�revleri.
PT888349E (pt) Pirrolopirimidinas e processos para a sua preparacao
ATE181224T1 (de) Medizinisches instrument für atherektomie
ATE8563T1 (de) Mittel zur hemmung des pflanzenwachstums.
EP1329459A3 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
MX9203159A (es) Iluminador de microscopio ajustable.
MX9302116A (es) Compuestos azabiciclo.
DK0459256T3 (da) Oxazolidiononer
DE59203986D1 (de) Vorrichtung für den Transport von Substraten.
ES2103280T3 (es) Anticuerpos monoclonales que inhiben el crecimiento del sarcoma de kaposi.
DE69325347D1 (de) Vorrichtung zur Kompensation des Postdurchlaufes
NO924361L (no) Formazan parasittiske midler
TR27540A (tr) Parazit nematodlarin kontrolü.
FI971891A0 (fi) Säätölaite aluksen pääenergialähteen tuottaman energian optimaalisen käytön saavuttamiseksi
ES2105633T3 (es) Derivados de pirimidinona condensada a heterociclos nitrogenados con actividad antagonista de a ii.
DK0505414T3 (da) Eliminering af aktiverede lymfocytter
ES2097435T3 (es) Derivados de 2,16-bispiperidinilandrostano monocuaternarios.
ES2083182T3 (es) Empleo de esteres de aminoalcanolamidas como agentes auxiliares de elaboracion de materias sinteticas termoplasticas.
ES2148753T3 (es) Sal de metilpirrolidinilindol.
HU9203732D0 (en) 5,6-dihydro-dibenz/b,e/azepin-6,11-dion-11-oximes abd process for their preparation
PT703916E (pt) Marcfortinas substituidas em 14 e derivados uteis como agentes antiparasiticos
ATA12591A (de) Einrichtung zur daempfung des von den raedern eines schienenfahrzeuges abgestrahlten schalles

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 450472

Country of ref document: ES